The target was the protein regulating gene peroxisome proliferator-activated receptor gamma (PPARg), which has been linked to several diseases such as obesity, diabetes, atherosclerosis, and cancer [7]. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.